Searched for
IPO EMCURE PHARMACEUTICALS
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.
- Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other detailsEmcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmace...
- Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Th...
- Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other detailsEmcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business imp...
- Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other detailsEmcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on ...
- Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscriptionEmcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO incl...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- IPO Calendar: Primary market gears up for another robust week as 3 companies look to raise Rs 2,700 crApart from the above 3 public offers, the Street will see as many 11 listings including that of Allied Blenders and Vraj Iron and Steel, wh...
- Emcure Pharma announces price band for Rs 1,952-crore IPO at Rs 960-1,008/share. Check GMP, other detailsEmcure Pharmaceuticals has announced its initial public offering (IPO) with a price band of Rs 960 to Rs 1,008 per equity share. The subscr...
- Ola Electric, Emcure Pharma get Sebi nod for IPOs, setting stage for big listingsThe Bengaluru-based company had filed its draft prospectus with Sebi in December last year. The issue comprises a fresh equity sale of Rs 5...
- Emcure Pharmaceuticals receives SEBI nod for its IPO launchEmcure Pharmaceuticals received SEBI nod for IPO launch after filing DRHP in December 2023. The IPO includes equity shares and an Offer of ...
- Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fameShark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February ...
- Emcure Pharmaceuticals gets Sebi's go-ahead to float IPOAs part of the OFS, promoters — Satish Mehta will offload 20.30 lakh equity shares, Sunil Mehta will sell 2.5 lakh equity shares — and inve...
- Emcure to soon file papers for Rs 4,000 crore IPOThe IPO will consist of a primary issue and offer for sale from its promoter Satish Mehta and existing investor Bain Capital which acquired...
- Generics company Emcure plans Rs 4,000 crore IPOEmcure may appoint as many as six bankers for the IPO including JM Financial, Kotak Capital, Axis Capital and SBI Capital, the people said....
- Emcure Pharmaceuticals withdraws proposed IPOThe Pune-based pharma company had filed draft offer documents with the Securities and Exchange Board of India (Sebi) for the proposed IPO i...
- Emcure Pharmaceuticals files DRHP for IPOEmcure Pharmaceuticals today said it has filed a DRHP with the SEBI for launching an initial public offer to raise an estimated Rs 300 cror...
- Emcure Pharmaceuticals files for 600 crore IPO, Blackstone to sell part stakeEmcure has appointed investment banks DSP Merrill Lynch, IDFC Capital and Morgan Stanley India Company Private to sell the issue.
Load More
